NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. >600 tests including molecular profiling in myeloid disorders and leukemias, cfDNA/RNA assays for biopsy-free evaluation of hematologic cancers, and >20 HemeFISH™ panels. Our Pharma Services division serves pharmaceutical clients in clinical trials and drug development from biomarker discovery thru CDx validation and commercialization.
NeoGenomics specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus for physicians to help them diagnose and treat cancer. The Company also serves pharmaceutical clients in clinical trials and drug development. As the leader in hematologic oncology testing, Neo offers a 500+ test menu, including comprehensive genomic profiling in hematologic cancers, broad portfolio of HemeFISH™ and Flow panels and cytogenetics.